{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-161124","form_type":"8-K","ticker":"OSUR","cik":"0001116463","company_name":"ORASURE TECHNOLOGIES INC","filed_at":"2022-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.803217+00:00","generated_at":"2026-06-25T06:37:53.374023+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OraSure appoints Carrie Eglinton Manner CEO effective June 4; ends strategic alternatives review","bullets":["Carrie Eglinton Manner appointed President and CEO, effective June 4, 2022; replaces interim CEO Nancy Gagliano.","Base salary $700k, target bonus 100% of base; equity awards: $4M RSU (2-year vest), $1.6M RSU (3-year vest), $1.6M performance RSU.","Board concludes strategic alternatives review; will proceed under new CEO, citing market conditions and belief in operational success.","Kathleen Weber, President of Molecular Solutions, resigns effective August 21, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-161124","json":"https://secwatch.observer/filing/0001193125-22-161124.json","markdown":"https://secwatch.observer/filing/0001193125-22-161124.md","text":"https://secwatch.observer/filing/0001193125-22-161124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522161124/0001193125-22-161124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522161124/d344918d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:37:53.374023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"815c9c958a","claim":"Carrie Eglinton Manner was appointed as Class I Director at ORASURE TECHNOLOGIES INC.","evidence_excerpt":"Ms. Eglinton Manner will be appointed by the Board to serve as a Class I director on the Board as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522161124/0001193125-22-161124-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"},{"claim_id":"a1c9a9217e","claim":"Carrie Eglinton Manner was appointed as President and Chief Executive Officer at ORASURE TECHNOLOGIES INC.","evidence_excerpt":"the board of directors (the “Board”) of the Company will appoint Ms. Eglinton Manner as the Company’s President and Chief Executive Officer, effective June 4, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522161124/0001193125-22-161124-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"dc4c1a2fde","claim":"Nancy J. Gagliano departed as Interim Chief Executive Officer at ORASURE TECHNOLOGIES INC.","evidence_excerpt":"Dr. Gagliano will resign, effective June 4, 2022, from her position as the Company’s interim Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000119312522161124/0001193125-22-161124-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resign"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}